SCHEMBL16626751

SCHEMBL16626751

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Cc3ccc(C(F)(F)F)cc3Cl)ccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.37
CYP3A5 P20815 1/20 0.37
S1PR1 P21453 1/20 0.37
NAMPT P43490 3/20 0.37
KMT2A Q03164 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A3 Q01959 1/20 0.37
ALDH1A1 P00352 1/20 0.36
PKM P14618 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
IDE P14735 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
HTR6 P50406 4/20 0.35
TSHR P16473 1/20 0.35
MEN1 O00255 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16618893 0.99 CYP3A4 (0.37) CYP3A4CYP3A5S1PR1NAMPTKMT2A
SCHEMBL17971579 0.90 SLC6A2 (0.38) NAMPTSLC6A4SLC6A2SLC6A3ALDH1A1
Hydrochloric Acid SCHEMBL16618994 0.89 SLC6A2 (0.37) NAMPTSLC6A4SLC6A2SLC6A3ALDH1A1
SCHEMBL16626636 0.89 PDE4A (0.42) NAMPTSLC6A4SLC6A2SLC6A3SMN1; SMN2
SCHEMBL16626647 0.89 NAMPT (0.39) NAMPTSLC6A4SLC6A2SLC6A3SMN1; SMN2
Hydrochloric Acid SCHEMBL16618813 0.88 PDE4A (0.42) NAMPTSLC6A4SLC6A2SLC6A3SMN1; SMN2
Hydrochloric Acid SCHEMBL16618888 0.88 NAMPT (0.38) NAMPTSLC6A4SLC6A2SLC6A3SMN1; SMN2
SCHEMBL16626646 0.88 HTR6 (0.39) IDEPDE4APDE4BPDE4CPDE4D
Hydrochloric Acid SCHEMBL16619388 0.87 HTR6 (0.39) IDEPDE4APDE4BPDE4CPDE4D
SCHEMBL16626431 0.85 NAMPT (0.38) CYP3A4CYP3A5S1PR1NAMPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI CYP3A4 564/4885CYP3A5 393/4885S1PR1 1297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.